| List | Section | Observation |
|---|---|---|
| Peru | 26. Ear Medications | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 21.1. Anti-infective agents |
Others observations: − Bacterial conjunctivitis − Bacterial keratitis Therapeutic alternatives: 4th level ATC chemical subgroup (S01AE Fluoroquinolones) |
| List | Section | Observation |
|---|---|---|
| Bolivia | LINAME 2011 - 2013 | No observations |
| Cuba | 6.2.8 Quinolonas, antisépticos y antiinfecciosos urinarios | No observations |
| PAHO Strategic Fund Medicine List | 2.2. Antileprosy med. |
Others observations: To be used in combination with rifampicin as a second-line therapy for leprosy treatment. |